Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.
The Nutshell
Daily News Roundup
Most Recent
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Charles Nemeroff, who was barred from receiving grants for 2 years in 2008, snags $401K from the NIH to study PTSD.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Research and funding organizations pledge to support a new system to support cross-border collaboration within the European Union.
Starting in April 2013, research supported by the United Kingdom government must be made freely available within 6 months of publication.
A trial comparing the effectiveness of robotic surgery and radiation for the treatment of throat cancer has begun in Canada.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
